China SXT Pharmaceuticals, Inc. Form 20-F: Annual report of foreign private issuer
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2026-07-01: Form 20-F; Period of report 2026-03-31; Description ANNUAL REPORT; Document ea0295524-20f_chinasxt.htm.
- 2025-07-31: Form 20-F; Period of report 2025-03-31; Description ANNUAL REPORT; Document ea0250010-20f_chinasxt.htm.
- 2024-08-13: Form 20-F; Period of report 2024-03-31; Description ANNUAL REPORT; Document ea0210141-20f_chinasxt.htm.
- 2023-07-31: Form 20-F; Period of report 2023-03-31; Description ANNUAL REPORT; Document f20f2023_chinasxtphar.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2026-07-01 | 20-F | 2026-03-31 | ANNUAL REPORT | ea0295524-20f_chinasxt.htm |
| 2025-07-31 | 20-F | 2025-03-31 | ANNUAL REPORT | ea0250010-20f_chinasxt.htm |
| 2024-08-13 | 20-F | 2024-03-31 | ANNUAL REPORT | ea0210141-20f_chinasxt.htm |
| 2023-07-31 | 20-F | 2023-03-31 | ANNUAL REPORT | f20f2023_chinasxtphar.htm |
| 2022-07-18 | 20-F | 2022-03-31 | ANNUAL REPORT | f20f2022_chinasxtphar.htm |
| 2021-08-13 | 20-F | 2021-03-31 | ANNUAL REPORT | f20f2021_chinasxtpharmaceuti.htm |
| 2020-07-31 | 20-F | 2020-03-31 | ANNUAL REPORT | f20f2020_chinasxtpharma.htm |
| 2019-08-15 | 20-F | 2019-03-31 | ANNUAL REPORT | f20f2019_chinasxtpharma.htm |